Atlas Trials

Atsushi Kawakami

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Atsushi Kawakami

RecordFirmDate
Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate (NCT05090410)Atsushi Kawakami2021-03-03
Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate (NCT05121298)Atsushi Kawakami2021-01-12

Track Atsushi Kawakami automatically

Every clearance here is in the API, with alerts when new ones post.